|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
|
|---|---|---|
| Operations | ||
| Net loss for the year | ||
| Adjustments for: | ||
| Finance cost | ||
| Finance income | ||
| Income tax | ||
| Foreign exchange | ||
| Share-based compensation | ||
| Amortization | ||
| Warintza royalty sale | ||
| Reclamation provision | ||
| Other | ||
| Net changes in non-cash working capital items: | ||
| Prepaids and other | ||
| Accounts payable and accrued liabilities | ||
| Reclamation provision settlement | ||
| Deferred revenue | ||
| Other long-term liability | ||
| Net cash flows from/(used in) operating activities | ||
| Financing | ||
| Proceeds from private placements of common shares | ||
| Proceeds from issuing of common shares | ||
| Proceeds from issuance of loans and borrowings | ||
| Share issuance and loan finance costs paid | ||
| Proceeds from the exercise of stock options | ||
| Loan drawdown | ||
| Loan repayment | ||
| Payment of lease liability | ||
| Contribution from non-controlling interest | ||
| Finance income received and other, net | ||
| Other finance costs paid | ||
| Net cash flows (used in)/from financing activities | ||
| Investing | ||
| Restricted cash contribution | ||
| Capital expenditures | ||
| Mineral Property Investment | ||
| Capital expenditure on property, plant and equipment | ||
| Capital expenditure on exploration and evaluation assets | ||
| Finance income received | ||
| Net cash flows used in investing activities | ||
| Effect of exchange rate change on cash and cash equivalents | ||
| Decrease in cash and cash equivalents | ||
| Cash and cash equivalents, beginning of year | ||
| Cash and cash equivalents, end of year |
Loading...
